SC 13G/A: Protagonist Therapeutics, Inc

AI Summary

SC 13G/A filing by Protagonist Therapeutics, Inc.

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.00001 — me of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securitie

Filing Documents

• p24-0672sc13ga.htm (SC 13G/A) — 62KB
• 0000902664-24-001553.txt ( ) — 64KB

(a)

Item 1(a). Name of Issuer. Protagonist Therapeutics, Inc. (the “ Issuer ”).

(b)

Item 1(b). Address of Issuer’s Principal Executive Offices. 7707 Gateway Boulevard, Suite 140, Newark, California 94560-1160.

(a)

Item 2(a). Name of Person Filing. This statement is filed by: (i) Point72 Asset Management, L.P. (“ Point72 Asset Management ”) with respect to shares of common stock, par value $0.00001 per share (“ Shares ”), of the Issuer held by an investment fund it manages; (ii) Point72 Capital Advisors, Inc. (“ Point72 Capital Advisors Inc .”) with respect to Shares held by an investment fund managed by Point72 Asset Management; and (iii) Steven A. Cohen (“ Mr. Cohen ”) with respect to Shares beneficially owned by Point72 Asset Management and Point72 Capital Advisors Inc.

(b)

Item 2(b). Address of Principal Business Office. The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902.

(c)

Item 2(c). Place of Organization. Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen.

(d)

Item 2(d). Title of Class of Securities. Common Stock, par value $0.00001 per share.

(e)

Item 2(e). CUSIP Number. 74366E102 Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a: Not applicable. Item 4. The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person. Such information is as of the close of business on December 31, 2023. Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own directly no Shares. Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power with respect to the securities held by an investment fund it manages. Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management. Mr. Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc.The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Shares reported herein. CUSIP No. 74366E102 13G/A Page 6 of 7 Pages Item 5. If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]. Item 6. See Item 2(a). Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below each Reporting Person certifies that, to the best of

View Full Filing

View this SC 13G/A filing on SEC EDGAR